Company Filing History:
5 out of 73 
1 out of 1 Years Active: 2013-2015
Title: Innovations and Contributions of Hong Liang Qian
Introduction
Hong Liang Qian is a prominent inventor based in Singapore, known for his significant contributions to the field of biotechnology. He holds a total of five patents, showcasing his expertise and innovative spirit in developing solutions for viral infections.
Latest Patents
Among his latest patents, one includes monoclonal antibodies specific to hemagglutinin from the influenza virus H5-subtype. These antibodies are designed for the detection and treatment of H5 subtype avian influenza virus (AIV) in various specimens. Another notable patent involves monoclonal antibodies that target both hemagglutinin and neuraminidase from influenza virus H5-subtype or N1-subtype. These antibodies are crucial for diagnosing, surveilling, and treating dangerous viral infections, including H5N1 subtypes.
Career Highlights
Hong Liang Qian has worked with esteemed organizations such as Temasek Life Sciences Laboratory Limited and the National Institute of Health Research and Development (NIHRD) under the Ministry of Health of the Republic of Indonesia. His work in these institutions has significantly advanced research in viral infections and antibody development.
Collaborations
He has collaborated with notable colleagues, including Fang He and Hwei-Sing Jimmy Kwang, contributing to various research projects and innovations in the field.
Conclusion
Hong Liang Qian's work exemplifies the impact of innovative research in biotechnology, particularly in combating viral infections. His patents and collaborations highlight his commitment to advancing medical science and public health.